With Parity Pricing, Gilead Relies On Genvoya Safety To Convert From Stribild
This article was originally published in The Pink Sheet Daily
Executive Summary
Genvoya includes a much smaller dose of tenofovir than Stribild, allowing for smaller pills, while its label also includes a number of safety advantages that Gilead can use in marketing.